Syno Capital is a global biotech and healthcare investment firm based in New York.
Founded in 2015, Syno Capital is a global investment firm focused on developing breakthrough innovations to meet our healthcare challenges. With our presence in New York, Hong Kong, and Shanghai, we want to work with the greatest minds no matter where they are to solve the toughest problems.
The firm has made investments in healthcare-related sectors such as biotechnology, medical, pharmaceutical, therapeutics, elder care, and personal health.
Dr. Justin Xiang is the Chief Investment Officer and Co-Founder of Syno Capital.
People
- Justin Xiang, Co-Founder & CIO
You last contacted this investor on .